Development Milestone Payment shall have the meaning set forth in Section 9.2(a).
Development Milestone is defined in Section 5.3.
Sales Milestone Payment shall have the meaning set forth in Section 8.4.
Milestone Payment Date has the meaning set forth in Section 2.4(a).
Development Milestone Event has the meaning set forth in Section 7.2.1.
Milestone means an event or task described in the Implementation Plan which must be completed by the corresponding date set out in such plan;
Performance Milestone means an act or event specified in section 5.1 and described in section 9 of the EPLA.
Project Milestone means the project milestone set forth in Schedule-J;
Milestone Payment has the meaning set forth in Section 4.2.
Initial Payment means the dollar amount specified as the “Initial Payment” in the applicable Purchase Agreement.
Milestone Date means the date set against the relevant Milestone in the Implementation Plan;
Milestone Events has the meaning set forth in Section 7.2.
Milestone Event has the meaning set forth in Section 8.2.1.
Milestone 2 means achievement of annual Net Sales of at least $35,000,000 during any Calendar Year ending on or before December 31, 2024.
Milestone 1 means achievement of annual Net Sales of at least $20,000,000 during the Calendar Year ending on December 31, 2021.
Initial Payment Date has the meaning specified in Section 3 of this Supplement.
Project Milestones means the project milestones set forth in Schedule-G;
Milestone Dates means the dates for completion of specified Project activities as contained in the Project Schedule.
Payout Amount means the vested portion of the Final Amount expressed as an amount of cash equal to the Fair Market Value of the shares of Stock underlying the RSUs and related Dividend Equivalents.
Milestone Notice has the meaning set forth in Section 2.4(a).
Milestone Payments means payments made in connection with any Permitted Acquisition or other acquisition (including any license or the acquisition of any license) of any rights in respect of any drug or other pharmaceutical product (and any related property or assets) to sellers (or licensors) of the assets or Equity Interests acquired (or licensed) therein based on the achievement of specified revenue, profit or other performance targets (financial or otherwise).
Earnout Amount has the meaning provided in Section 2.9(b).
Closing Payment Amount has the meaning specified in Section 1.5.
Earnout Payment has the meaning set forth in Section 2.3(b).
M1 Target Amount With respect to any Distribution Date, an amount equal to the lesser of (a) the product of (i) 70.00% and (ii) the Pool Balance for such Distribution Date and (b) the amount, if any, by which (i) the Pool Balance for such Distribution Date exceeds (ii) 0.50% of the Cut-off Date Balance.
M5 Target Amount With respect to any Distribution Date, an amount equal to the lesser of (a) the product of (i) 86.20% and (ii) the Aggregate Pool Balance for such Distribution Date determined as of the last day of the related Collection Period and (b) the amount, if any, by which (i) the Aggregate Pool Balance for such Distribution Date determined as of the last day of the related Collection Period exceeds (ii) the Targeted Overcollateralization Amount.